Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    85.7%

    Based on 6 completed trials

    Completion Rate
    86%(6/7)
    Active Trials
    0(0%)
    Results Posted
    83%(5 trials)
    Terminated
    1(14%)

    Phase Distribution

    Phase 4
    2
    29%
    Not Applicable
    1
    14%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    2

    Late Stage

    Phase Distribution3 total trials
    Phase 4Post-market surveillance
    2(66.7%)
    N/ANon-phased studies
    1(33.3%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    85.7%

    6 of 7 finished

    Non-Completion Rate

    14.3%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    7

    all time

    Status Distribution
    Completed(6)
    Terminated(1)

    Detailed Status

    Completed6
    Terminated1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    7
    Active
    0
    Success Rate
    85.7%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 42 (66.7%)
    N/A1 (33.3%)

    Trials by Status

    completed686%
    terminated114%

    Recent Activity

    0 active trials
    Showing 5 of 7
    completed

    GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

    NCT04706273
    completednot_applicable

    In-Stent Restenosis Post-Approval Study

    NCT02542267
    completed

    Treatment of Patients With Traumatic or Iatrogenic Vessel Injuries

    NCT05183399
    completed

    Evaluation of the GORE® VIABAHN® Endoprosthesis for the Treatment of Popliteal Artery Aneurysm (PAA)

    NCT02462876
    terminated

    Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm

    NCT01902888
    View all 7 trials

    Clinical Trials (7)

    Showing 7 of 7 trials
    NCT04706273

    GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

    Completed
    NCT02542267Not Applicable

    In-Stent Restenosis Post-Approval Study

    Completed
    NCT05183399

    Treatment of Patients With Traumatic or Iatrogenic Vessel Injuries

    Completed
    NCT02462876

    Evaluation of the GORE® VIABAHN® Endoprosthesis for the Treatment of Popliteal Artery Aneurysm (PAA)

    Completed
    NCT01902888

    Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm

    Terminated
    NCT01108861Phase 4

    GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis

    Completed
    NCT00228384Phase 4

    GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study

    Completed

    All 7 trials loaded

    Drug Details

    Intervention Type
    Device
    Total Trials
    7